Soleus Capital Master Fund, L.P. 13D and 13G filings for Mural Oncology plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-05 5:00 pm Purchase | 2025-06-30 | 13G | Mural Oncology plc MURA | Soleus Capital Master Fund, L.P. | 1,323,877 7.600% | 243,950 (+22.59%) | Filing |
| 2025-04-16 5:37 pm Purchase | 2025-04-15 | 13G | Mural Oncology plc MURA | Soleus Capital Master Fund, L.P. | 1,079,927 6.300% | 1,079,927 (New Position) | Filing |